Episode Details
Back to Episodes
Episode 42: Establishing a New Drug Therapy
Published 6 years, 7 months ago
Description
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering space and how it’s planning to add a new therapeutic option for patients, what it means to establish a new therapy in a statin-dominated market, market research approaches, and more.